期刊文献+

宫颈特殊染色法在宫颈病变筛查中价值的研究 被引量:20

Study on the value of cervical special staining in screening of cervical lesions
原文传递
导出
摘要 目的探讨叶酸受体介导的宫颈特殊染色法在宫颈癌及癌前病变筛查中的应用价值。方法选取2014年1月-2015年7月来医院就诊的患者同时行FRD宫颈特殊染色检测、液基细胞学(TCT)检测,两者任一项提示异常(FRD提示阳性、细胞学提示AGC或≥LSIL)者行阴道镜检查,以病理结果为金标准,比较两者临床诊断价值。结果纳入病例204例,在宫颈癌及癌前病变的筛查中FRD特殊染色、TCT检查两种检验技术敏感度分别为91.20%、84.00%,特异性分别为62.03%、63.29%,诊断符合率分别为79.90%、75.98%,阳性预测值分别为79.17%、78.36%,阴性预测值分别为81.67%、71.43%,Kappa值分别为0.56、0.48。FRD特殊染色与TCT检查结果差异无统计学意义(P>0.05)。结论 FRD特殊染色、TCT检查两种检验技术在宫颈病变中的筛查意义无明显差异,但FRD特殊染色操作简便、结果快速、成本低廉,值得应用于临床。 Abstract: Objective To explore the application value of folic acid receptor-mediated cervical special staining in screening of cervical cancer and cervical precancerous lesion. Methods The patients with one abnormal result of cervical special staining or TCT ( positive cervi-' cal special staining result, cytology test indicated AGC or≥ LSIL) treated in the hospital from Janaury 2014 to July 2015 were selected; pathological result was designed as gold standard ; the clinical diagnostic values of the two method were compared. Results A total of 204 cases were included; the sensitivities of cervical special staining and TCT were 91.20% and 84. 00%, respectively; the specificities were 62. 03% and 63.29 %, respectively; the diagnostic coincidence rates were 79. 90% and 75.98%, respectively; the positive predictive val- ues were 79. 17% and 78. 36%, respectively; the negative predictive values were 81.67% and 71.43%, respectively; Kappa values were 0.56 and 0. 48, respectively. There was no statistically significant difference between cervical special staining and TCT (P〉0.05) . Con- clusion There was no statistically significant difference between cervical special staining and TCT in screening of cervical lesions, but cervi- cal special staining is easier, faster, and cheaoer, which is worthy of clinical application.
出处 《中国妇幼保健》 CAS 2016年第4期835-837,共3页 Maternal and Child Health Care of China
基金 北京市科委项目(D151100001915001)
关键词 叶酸受体介导 宫颈特殊染色 宫颈癌 宫颈癌前病变 筛查 Folic acid receptor-mediated Cervical special staining Cervical cancer Cervical precancerous lesion Screening
  • 相关文献

参考文献11

  • 1Priebe AM.2012 cervical cancer screening guidelines and the future role of HPV testing[J].Clin Obstet Gynecol,2013,56(1):44-50. 被引量:1
  • 2郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 3Bengtsson E,Malm P.Screening for cervical cancer using automated analysis of PAP-smears[J].Computat Math Methods Med,2014,2014:(2014):1-2. 被引量:1
  • 4Crane LMA,Arts HJG,van Oosten M,et al.The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer[J].Cell Oncol,2012,35(1):9-18. 被引量:1
  • 5黄英男,吴昊,沈锡中.叶酸受体在肿瘤靶向诊断和治疗中的应用[J].复旦学报(医学版),2012,39(1):74-79. 被引量:13
  • 6黄受方.新版《子宫颈细胞学Bethesda报告系统》读后感[J].诊断病理学杂志,2005,12(3):161-163. 被引量:53
  • 7López-Alegría F,Poblete OQ,Lorenzi DSD,et al.Clinical management of the first ASCUS report in Chile.Prospective single-cohort study[J].Sao Paulo Med J,2015,133(6):480-487. 被引量:1
  • 8Andrae B,Kemetli L,Sparén P,et al.Screening-preventable cervical cancer risks:evidence from a nationwide audit in Sweden[J].J Nat Cancer Inst,2008,100(9):622-629. 被引量:1
  • 9Saslow D,Solomon D,Lawson HW,et al.American Cancer Society,American Society for Colposcopy and Cervical Pathology,and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J].CA Cancer J Clin,2012,62(3):147-172. 被引量:1
  • 10Sudimack J,Lee RJ.Targeted drug delivery via the folate receptor[J].Adv Drug Deliv Rev,2000,41(2):147-162. 被引量:1

二级参考文献51

  • 1万丹晶,钟高仁,朱建华,丁建辉,曾盟苏.叶酸受体靶向磁共振对比剂^(157)Gd-DTPA-Folate增强裸鼠肿瘤信号的初期评估[J].核技术,2006,29(8):605-608. 被引量:6
  • 2钱慧敏,陈海燕,王旻,顾月清.近红外标记技术在生物医药领域的应用[J].药物生物技术,2006,13(4):306-309. 被引量:14
  • 3Alberg AJ,Selhub J, Shah KV, et al. The risk of cervical cancer in relation to serum concentrations of folate vitamin B12,and homocysteine[J]. Cancer Epidemiol Biomarkers PrevG,2000,9(7) :761 - 764. 被引量:1
  • 4Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia:a review[J]. J Nutr,2002, 132 (8 Suppl) :2350S - 2355S. 被引量:1
  • 5Sudimack J,Lee RJ. Targeted drug delivery via the folate reeeptor[J]. Adv Drug Deliv Rev,2000,41(2) 147 - 162. 被引量:1
  • 6Kamen BA,Smith AK. A review of folate receptor alpha cycling and 5 methyltetrahydrofolate accumulation with an emphasis on cell models in vitro[J]. Adv Drug Deliv Rev,2004,56(8) :1085 - 1097. 被引量:1
  • 7Vlashi E, Sturgis JE, Thomas M, et al. Real time, noninva sive imaging and quantitation of the accumulation of lig- and-targeted drugs into receptor expressing solid tumors [J]. Mol Pharm ,2009,6(6) : 1868-1875. 被引量:1
  • 8I.eamon CP,Parker MA, Vlahov IR,et al. Synthesis and biological evaluation of EC20:a new folate derived, (99m) Tc-based radiopharmaceutical[J]. Bioconjug Chem, 2002, 13(6) :1200-1210. 被引量:1
  • 9Reddy JA, Xu LC, Parker N, et al. Preclinical evaluation of (99m)TcEC20 for imaging folate receptor-positive tumors[J]. J NuclMed,2004,45(5):857-866. 被引量:1
  • 10Choi H,Choi SR, Zhou R, et al. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery [J]. Acad Radiol,2004,11 (9) :996 - 1004. 被引量:1

共引文献152

同被引文献114

引证文献20

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部